Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05552664 · ClinicalTrials.gov registry record · NA

The Genetic Information and Family Testing (GIFT) Study

A NA study of Cancer, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
NA
Development phase
3,002
Enrollment target
4
Study locations

NCT05552664 is a NA study of Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 3,002 participants, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05552664, a NA study of Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
NA
Development phase
3,002 participants
Enrollment target
4
Study locations

Study Summary

The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) and prepare them to subsequently engage their clinicians in informed decision-making about cancer prevention and early detection.

Conditions Studied

Interventions

  • GENETIC GIFT

Study Locations (4)

California

  • University of Southern California - Los Angeles
  • Stanford University - Stanford

Georgia

  • Emory University - Atlanta

Michigan

  • University of Michigan Rogel Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 3,002 participants
Start Date 2022-10-24
Est. Completion 2025-08-10
Phase NA

What the Registry Record Tells You About NCT05552664

The ClinicalTrials.gov registry entry for NCT05552664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,002 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which GIFT is the first listed.

NCT05552664 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Georgia, Michigan.

Frequently Asked Questions

What is clinical trial NCT05552664 about?

NCT05552664 is a clinical study titled "The Genetic Information and Family Testing (GIFT) Study". The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) ...

What is the current status of trial NCT05552664?

This trial is currently completed. It is a NA study. The enrollment target is 3,002 participants. The study started on 2022-10-24. Estimated completion is 2025-08-10.

What conditions does trial NCT05552664 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05552664?

The interventions under investigation include: GIFT (GENETIC).

Who is sponsoring clinical trial NCT05552664?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05552664 being conducted?

This trial has 4 study locations across California, Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.